The ACTN3 R577X polymorphism is associated with inflammatory myopathies in a Mexican population

Area of Science:

• Genetics
• Muscle Biology
• Immunology

Background:

• The ACTN3 gene encodes α-actinin-3, a fast muscle protein.
• The R577X polymorphism creates a premature stop codon, leading to α-actinin-3 absence in 577XX homozygotes.
• Idiopathic inflammatory myopathies (IIMs) are a group of autoimmune diseases affecting muscles.

Purpose of the Study:

• To investigate the association between ACTN3 genotypes and IIMs.
• To determine the frequency of ACTN3 R577X polymorphism in patients with IIMs.
• To explore the relationship between ACTN3 genotype and disease severity markers.

Main Methods:

• ACTN3 genotyping was performed using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP).
• Genotyping was conducted on 27 patients with dermatomyositis (DM), 10 with polymyositis (PM), and 85 healthy controls.
• Muscle enzyme levels (CPK, LDH, AST, ALT) were recorded at diagnosis and recruitment.

Main Results:

• The ACTN3 577X allele was significantly more frequent in IIM patients (82%) compared to healthy subjects (59%), increasing IIM risk (OR 3.21).
• Specifically, 70% of IIM patients had the 577XX genotype (α-actinin-3 deficiency), compared to 36% in controls.
• The ACTN3 577X allele was associated with an increased risk of IIM, particularly DM, but not disease severity.

Conclusions:

• The ACTN3 577X allele is a potential risk factor for developing IIM, with a high prevalence of α-actinin-3 deficiency in affected individuals.
• Conversely, ACTN3 577XX genotypes may be linked to milder IIM phenotypes, indicated by lower muscle enzyme levels.
• Further research is warranted to elucidate the precise role of ACTN3 in IIM pathogenesis and clinical presentation.